News
XyloCor Therapeutics, a clinical-stage biopharmaceutical company focused on developing novel therapies for cardiovascular disease, announced the first patient has been dosed in the Phase 2b EXACT-2 ...
The Cool Down on MSN13h
Officials issue warning following concerning series of animal attacks on humans — here's what you need to knowLocal station WRAL News reported in early June that the animal later tested positive for rabies and that the inspector began ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback